RSP Systems A/S
16
0
0
12
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 75/100
18.8%
3 terminated/withdrawn out of 16 trials
80.0%
-6.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 12 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (16)
Performance and Safety Evaluation of a Novel Non-invasive Glucose Monitoring Device
Role: lead
Device Accuracy of Non-invasive Glucose Measurements in Ethnic Skin
Role: lead
A Study of a Non-invasive Glucose Measuring Device in Out-patient Settings
Role: lead
Study of a Non-invasive Glucose Measuring Device
Role: lead
Study of a Novel Non-invasive Glucose Monitoring Device
Role: lead
Performance Study of a Non-invasive Glucose Monitoring Device Prototype
Role: lead
Calibration of a Non-invasive Glucose Measurement Device and Assessment of Its Performance in the Hypoglycemic Range in Patients With Type 1 Diabetes
Role: lead
Performance and Safety Evaluation of a Novel Non-invasive Glucose Monitoring Device and Evaluation of the Instructions for Use
Role: lead
Noninvasive Glucose Measurements - Database and Calibration Compilation
Role: lead
Performance Characteristics of Non-invasive Glucose Monitoring Device Prototypes
Role: lead
Performance Evaluation of a Novel Non-invasive Glucometer, Calibrated Against Validated Interstitial Glucose References
Role: lead
Database and Calibration of a Non-invasive Glucose Monitoring Device
Role: lead
Non-invasive Glucose Measurement With Raman Technology in Patients With Type 1 and Type 2 Diabetes
Role: lead
Ex Vivo Evaluation of Laser Induced Thermal Tissue Damage
Role: lead
Comparative Study Between Two Models of a Non-invasive Glucose Monitoring Device
Role: lead
Performance Characteristics and Safety Assessment of a Non-invasive Glucose Monitoring Device
Role: lead
All 16 trials loaded